263 related articles for article (PubMed ID: 23713803)
1. Is esophagogastroduodenoscopy necessary in patients with positive fecal occult blood tests and negative colonoscopy?
Choi JS; Choi JY; Cho HG; Han KJ; Kim HM; Cho JH; Kim YJ
Scand J Gastroenterol; 2013 Jun; 48(6):657-62. PubMed ID: 23713803
[TBL] [Abstract][Full Text] [Related]
2. Prospective evaluation of gastrointestinal lesions by bidirectional endoscopy in patients with iron deficiency anemia.
Pongprasobchai S; Sriprayoon T; Manatsathit S
J Med Assoc Thai; 2011 Nov; 94(11):1321-6. PubMed ID: 22256471
[TBL] [Abstract][Full Text] [Related]
3. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.
van Rossum LG; van Rijn AF; Laheij RJ; van Oijen MG; Fockens P; van Krieken HH; Verbeek AL; Jansen JB; Dekker E
Gastroenterology; 2008 Jul; 135(1):82-90. PubMed ID: 18482589
[TBL] [Abstract][Full Text] [Related]
4. Yield of dual endoscopy for positive fecal occult blood test.
Ali M; Yaqub M; Haider Z; Anees I; Bhargava S; Gian J
Am J Gastroenterol; 2003 Jan; 98(1):82-5. PubMed ID: 12526941
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of gastric cancer versus colorectal cancer in Asians with a positive fecal occult blood test.
Day LW; Cello JP; Somsouk M; Inadomi JM
Indian J Gastroenterol; 2011 Sep; 30(5):209-16. PubMed ID: 21948130
[TBL] [Abstract][Full Text] [Related]
6. Gastroenterologists' practice patterns for positive fecal occult blood test.
Kim JJ; Han A; Yan AW; Cao D; Laine L
J Clin Gastroenterol; 2014 Feb; 48(2):119-26. PubMed ID: 23632353
[TBL] [Abstract][Full Text] [Related]
7. Positive predictive value of fecal occult blood testing in persons taking warfarin.
Bini EJ; Rajapaksa RC; Weinshel EH
Am J Gastroenterol; 2005 Jul; 100(7):1586-92. PubMed ID: 15984986
[TBL] [Abstract][Full Text] [Related]
8. Sensitivity of immunochemical fecal occult blood test to small colorectal adenomas.
Morikawa T; Kato J; Yamaji Y; Wada R; Mitsushima T; Sakaguchi K; Shiratori Y
Am J Gastroenterol; 2007 Oct; 102(10):2259-64. PubMed ID: 17617203
[TBL] [Abstract][Full Text] [Related]
9. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population.
Guittet L; Bouvier V; Mariotte N; Vallee JP; Arsène D; Boutreux S; Tichet J; Launoy G
Gut; 2007 Feb; 56(2):210-4. PubMed ID: 16891354
[TBL] [Abstract][Full Text] [Related]
10. A prospective study of bidirectional endoscopy (colonoscopy and upper endoscopy) in the evaluation of patients with occult gastrointestinal bleeding.
Zuckerman G; Benitez J
Am J Gastroenterol; 1992 Jan; 87(1):62-6. PubMed ID: 1728127
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance colonography for the detection of colorectal neoplasia in asymptomatic adults.
Graser A; Melzer A; Lindner E; Nagel D; Herrmann K; Stieber P; Schirra J; Mansmann U; Reiser MF; Göke B; Kolligs FT
Gastroenterology; 2013 Apr; 144(4):743-750.e2. PubMed ID: 23415805
[TBL] [Abstract][Full Text] [Related]
12. Relative frequency of upper gastrointestinal and colonic lesions in patients with positive fecal occult-blood tests.
Rockey DC; Koch J; Cello JP; Sanders LL; McQuaid K
N Engl J Med; 1998 Jul; 339(3):153-9. PubMed ID: 9664091
[TBL] [Abstract][Full Text] [Related]
13. Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer.
Denters MJ; Deutekom M; Bossuyt PM; Stroobants AK; Fockens P; Dekker E
Gastroenterology; 2012 Mar; 142(3):497-504. PubMed ID: 22108194
[TBL] [Abstract][Full Text] [Related]
14. Clinical features of upper gastrointestinal serrated lesions: An endoscopy database analysis of 98746 patients.
Cao HL; Dong WX; Xu MQ; Zhang YJ; Wang SN; Piao MY; Cao XC; Wang BM
World J Gastroenterol; 2016 Dec; 22(45):10038-10044. PubMed ID: 28018111
[TBL] [Abstract][Full Text] [Related]
15. Gastroscopy following a positive fecal occult blood test and negative colonoscopy: systematic review and guideline.
Allard J; Cosby R; Del Giudice ME; Irvine EJ; Morgan D; Tinmouth J
Can J Gastroenterol; 2010 Feb; 24(2):113-20. PubMed ID: 20151070
[TBL] [Abstract][Full Text] [Related]
16. Fecal occult blood testing for colorectal cancer screening: use the finger.
Burke CA; Tadikonda L; Machicao V
Am J Gastroenterol; 2001 Nov; 96(11):3175-7. PubMed ID: 11721767
[TBL] [Abstract][Full Text] [Related]
17. Esophago-gastro-duodenoscopy is not indicated in patients with positive immunochemical test and nonexplanatory colonoscopy.
Levi Z; Vilkin A; Niv Y
Eur J Gastroenterol Hepatol; 2010 Dec; 22(12):1431-4. PubMed ID: 20962660
[TBL] [Abstract][Full Text] [Related]
18. Screening for familial colorectal cancer with a sensitive immunochemical fecal occult blood test: a pilot study.
Gimeno-García AZ; Quintero E; Nicolás-Pérez D; Hernández-Guerra M; Parra-Blanco A; Jiménez-Sosa A
Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):1062-7. PubMed ID: 19307978
[TBL] [Abstract][Full Text] [Related]
19. [Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?].
Quintero E
Gastroenterol Hepatol; 2009 Oct; 32(8):565-76. PubMed ID: 19577340
[TBL] [Abstract][Full Text] [Related]
20. Screening for gastrointestinal neoplasia: efficacy and cost of two different approaches in a clinical rehabilitation centre.
Manus B; Brägelmann R; Armbrecht U; Stolte M; Stockbrügger RW
Eur J Cancer Prev; 1996 Feb; 5(1):49-55. PubMed ID: 8664809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
